Pygeum
•Last Updated: September 28 2022
Pygeum is an extract made from the the bark of the Prunus africana tree. It is commonly sold as a supplement for prostate health.
Pygeum is most often used for
Last Updated: September 28 2022
Pygeum is an herbal supplement derived from the bark of the Prunus africana tree.
Pygeum is often sold as a prostate health supplement, specifically to alleviate Benign Prostatic Hyperplasia (BPH), also called benign enlargement of the prostate.
Further research is needed to determine if pygeum does exert this protective effect. Though one meta-analysis showed pygeum supplementation provides overall benefits for BPH, subsequent studies suffered from poor design and do not provide strong evidence.
Pygeum has been shown to reduce BPH proliferation in vitro (in a test tube) by interfering with growth factors. It also has an anti-androgenic effect on its receptor. Additional studies are needed to determine if this effect takes place inside the human body after oral supplementation.
Pygeum should not be confused with:
- Pycnogeol (Pine bark extract)
Most prostate health supplements and scientific studies use a dose of 50-100mg of pygeum , taken daily.
Additional research is needed to determine the optimal dose of pygeum bark.
What works and what doesn't?
Unlock the full potential of Examine
1.^Hutchison A, Farmer R, Verhamme K, Berges R, Navarrete RVThe efficacy of drugs for the treatment of LUTS/BPH, a study in 6 European countriesEur Urol.(2007 Jan)
2.^Edgar AD, Levin R, Constantinou CE, Denis LA critical review of the pharmacology of the plant extract of Pygeum africanum in the treatment of LUTSNeurourol Urodyn.(2007)
3.^Stewart KMThe African cherry (Prunus africana): can lessons be learned from an over-exploited medicinal treeJ Ethnopharmacol.(2003 Nov)
5.^Paubert-Braquet M, Cave A, Hocquemiller R, Delacroix D, Dupont C, Hedef N, Borgeat PEffect of Pygeum africanum extract on A23187-stimulated production of lipoxygenase metabolites from human polymorphonuclear cellsJ Lipid Mediat Cell Signal.(1994 May)
6.^Schleich S, Papaioannou M, Baniahmad A, Matusch RExtracts from Pygeum africanum and other ethnobotanical species with antiandrogenic activityPlanta Med.(2006 Jul)
7.^Schleich S, Papaioannou M, Baniahmad A, Matusch RActivity-guided isolation of an antiandrogenic compound of Pygeum africanumPlanta Med.(2006 May)
8.^Kadu CA, Parich A, Schueler S, Konrad H, Muluvi GM, Eyog-Matig O, Muchugi A, Williams VL, Ramamonjisoa L, Kapinga C, Foahom B, Katsvanga C, Hafashimana D, Obama C, Vinceti B, Schumacher R, Geburek TBioactive constituents in Prunus africana: geographical variation throughout Africa and associations with environmental and genetic parametersPhytochemistry.(2012 Nov)
9.^Ganzera M, Croom EM, Khan IADetermination of the Fatty Acid content of pumpkin seed, pygeum, and saw palmettoJ Med Food.(1999)
10.^Hass MA, Nowak DM, Leonova E, Levin RM, Longhurst PAIdentification of components of Prunus africana extract that inhibit lipid peroxidationPhytomedicine.(1999 Nov)
12.^Catalano S, Ferretti M, Marsili A, Morelli INew constituents of Prunus africana bark extractJ Nat Prod.(1984 Sep-Oct)
13.^10 Metabolomics profiles of prostatic secretions from patients treated by Pygeum Africanum for low urinary tract symptoms related to benign prostatic hyperplasia.()
14.^Hartmann RW, Mark M, Soldati FInhibition of 5 α-reductase and aromatase by PHL-00801 (Prostatonin®), a combination of PY102 (Pygeum africanum) and UR102 (Urtica dioica) extractsPhytomedicine.(1996 Sep)
15.^Shenouda NS, Sakla MS, Newton LG, Besch-Williford C, Greenberg NM, MacDonald RS, Lubahn DBPhytosterol Pygeum africanum regulates prostate cancer in vitro and in vivoEndocrine.(2007 Feb)
16.^Roell D, Baniahmad AThe natural compounds atraric acid and N-butylbenzene-sulfonamide as antagonists of the human androgen receptor and inhibitors of prostate cancer cell growthMol Cell Endocrinol.(2011 Jan 30)
17.^Papaioannou M, Schleich S, Roell D, Schubert U, Tanner T, Claessens F, Matusch R, Baniahmad ANBBS isolated from Pygeum africanum bark exhibits androgen antagonistic activity, inhibits AR nuclear translocation and prostate cancer cell growthInvest New Drugs.(2010 Dec)
18.^Handratta VD, Vasaitis TS, Njar VC, Gediya LK, Kataria R, Chopra P, Newman D Jr, Farquhar R, Guo Z, Qiu Y, Brodie AMNovel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft modelJ Med Chem.(2005 Apr 21)
19.^Mathé G, Orbach-Arbouys S, Bizi E, Court BThe so-called phyto-estrogenic action of Pygeum africanum extractBiomed Pharmacother.(1995)
20.^Papaioannou M, Schleich S, Prade I, Degen S, Roell D, Schubert U, Tanner T, Claessens F, Matusch R, Baniahmad AThe natural compound atraric acid is an antagonist of the human androgen receptor inhibiting cellular invasiveness and prostate cancer cell growthJ Cell Mol Med.(2009 Aug)
21.^Bach SM, Perotti ME, Merep AP, Marcial GE, Grau A, Attarian R, Av-Gay Y, Bach H, Catalán CAChemical constituents, anti-inflammatory and antioxidant activities of bark extracts from Prunus tucumanensis LilloNat Prod Res.(2012 Mar 9)
22.^Boulbès D, Soustelle L, Costa P, Haddoum M, Bali JP, Hollande F, Magous RPygeum africanum extract inhibits proliferation of human cultured prostatic fibroblasts and myofibroblastsBJU Int.(2006 Nov)
23.^Inhibition of bFGF and EGF-induced proliferation of 3T3 fibroblasts by extract of Pygeum africanum (Tadenan®).()
24.^Yablonsky F, Nicolas V, Riffaud JP, Bellamy FAntiproliferative effect of Pygeum africanum extract on rat prostatic fibroblastsJ Urol.(1997 Jun)
25.^Quiles MT, Arbós MA, Fraga A, de Torres IM, Reventós J, Morote JAntiproliferative and apoptotic effects of the herbal agent Pygeum africanum on cultured prostate stromal cells from patients with benign prostatic hyperplasia (BPH)Prostate.(2010 Jul 1)
26.^Larré S, Camparo P, Comperat E, Boulbés D, Haddoum M, Baulande S, Soularue P, Costa P, Cussenot OBiological effect of human serum collected before and after oral intake of Pygeum africanum on various benign prostate cell culturesAsian J Androl.(2012 May)
27.^Wilt T, Ishani A, Mac Donald R, Rutks I, Stark GPygeum africanum for benign prostatic hyperplasiaCochrane Database Syst Rev.(2002)
28.^Barry MReview: Pygeum africanum extracts improve symptoms and urodynamics in symptomatic benign prostatic hyperplasiaACP J Club.(2002 Sep-Oct)
29.^Ishani A, MacDonald R, Nelson D, Rutks I, Wilt TJPygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysisAm J Med.(2000 Dec 1)
30.^Melo EA, Bertero EB, Rios LA, Mattos D JrEvaluating the efficiency of a combination of Pygeum africanum and stinging nettle (Urtica dioica) extracts in treating benign prostatic hyperplasia (BPH): double-blind, randomized, placebo controlled trialInt Braz J Urol.(2002 Sep-Oct)
31.^Krzeski T, Kazón M, Borkowski A, Witeska A, Kuczera JCombined extracts of Urtica dioica and Pygeum africanum in the treatment of benign prostatic hyperplasia: double-blind comparison of two dosesClin Ther.(1993 Nov-Dec)
32.^Breza J, Dzurny O, Borowka A, Hanus T, Petrik R, Blane G, Chadha-Boreham HEfficacy and acceptability of tadenan (Pygeum africanum extract) in the treatment of benign prostatic hyperplasia (BPH): a multicentre trial in central EuropeCurr Med Res Opin.(1998)
33.^Chatelain C, Autet W, Brackman FComparison of once and twice daily dosage forms of Pygeum africanum extract in patients with benign prostatic hyperplasia: a randomized, double-blind study, with long-term open label extensionUrology.(1999 Sep)
37.^Wang D, Li Y, Hou G, Wang P, Zhang J, Laudon V, Shi BPygeum africanum: effect on oxidative stress in early diabetes-induced bladderInt Urol Nephrol.(2010 Jun)
38.^Foster BA, Gingrich JR, Kwon ED, Madias C, Greenberg NMCharacterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) modelCancer Res.(1997 Aug 15)
Primary Use